Susquehanna Upgrades RXO to Neutral, Lowers Price Target to $19

Benzinga · 1d ago
Susquehanna analyst Harrison Bauer upgrades RXO (NYSE:RXO) from Negative to Neutral and lowers the price target from $20 to $19.